Last month, a surgeon performed ophthalmology’s first robot-assisted surgery – a membrane peel. Marc de Smet, chief medical officer of Preceyes, a Dutch start-up, shares the company’s history and plans for the future.

Backed by nearly $30 million from the Department of Defense, BrainScope created a device to make concussion diagnosis more certain. Hear what’s next for the Medtech start-up.

Ashley McEvoy, Company Group Chairman, Johnson & Johnson Vision Care and Johnson & Johnson Diabetes Care Companies, says the new force could pursue M&A in future expansion. Hear the details of the deal.

Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.

Chen Yu, MD, managing director of Vivo Capital, has built a career finding the right deals at the right time in the US and China. Hear what US companies can do to take advantage of potential Pan Pacific opportunities.

Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers for ophthalmology and life sciences. Norris’ first-half numbers for Medtech start-ups show some surprising sources of strength for the sector.

ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.

Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and start-ups, now leads what looks to be a new leader in ophthalmology. Hear how Mazzo views this new opportunity for Zeiss and himself.

Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San Francisco – helped launch a “moonshot” that would eventually restore vision for retinitis pigmentosa patients. In this podcast we discuss what drives him and what’s next for ophthalmology.